Improving patient outcomes and experiences through remote wound monitoring.

Our team came together as part of the inaugural Texas Biodesign program, which teaches a needs-based approach to innovation in the medical sector. The team identified several quality needs, eventually leading to the concept that became iDetect.

We were selected as an E-Team in the VentureWell program at the Pioneer and Propel levels. Its workshops gave us coaching, mentorship, and a series of customer discovery interviews that sharpened our value propositions and market strategy.

After completing Texas Biodesign, the team began developing iDetect and incorporated Longhorn Life Sciences as a Delaware C Corp.

We have sought out strategic partnerships, including established wound care device manufacturers, the Department of Defense, and NASA’s Office of Technology Transfer.

We have competed in the Texas Venture Labs Investment Competition on four occasions, winning it in Fall 2024 along with several additional awards, including the award for top health innovation. We were an alternate for the Texas A&M New Ventures Competition, where we won the elevator pitch and two other awards, and were invited to pitch at Project Medtech in 2024.

Led by Dr. Miles Massidda, Dr. Cristina Checka, and students in the Texas Venture Labs Practicum, the team has completed 140 customer discovery interviews, in part through the VentureWell and Washington University Equalize mentorship programs. The interviews have targeted doctors, nurses, patients, and clinical purchasing teams to validate the clinical need, mitigate regulatory hurdles, and identify viable sales channels.